IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkins disease and non-Hodgkins lymphomas, different forms of leukemias, breast and colorectal carcinomas and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 can be useful marker of cell proliferation during monitoring of tumor progression.

Store undiluted at 2-8°C.DO NOT FREEZE!Shelf life: one year from despatch.

Format

Preservatives:

0.05% Sodium Azide

State:

Liquid Bioreactor ConcentrateSupernatant

Species Reactivity

Species reactivity (tested):

Human, Mouse, Rat.

Specificity

Specificity:

Recognizes a protein of 14-16kDa, which is a novel nuclear antigen of proliferating cells. IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin’s disease and non-Hodgkin’s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 can be a useful marker of cell proliferation during monitoring of tumor progression. Cellular Localization: Nuclear.